Benzinga's Top Pre-Market Gainers

K12 (NYSE: LRN) soared 13.66% to $24.30 in the pre-market trading. K12 reported a better-than-expected fourth-quarter profit.

Vical (NASDAQ: VICL) surged 9.28% to $4.12 in the pre-market session. Vical announced today a worldwide, nonexclusive license to Bristol-Myers Squibb Company (NYSE: BMY).

Cliffs Natural Resources (NYSE: CLF) added 2.41% to $41.60 in the pre-market session. Cliffs Natural Resources' PEG ratio is 1.09.

Arena Pharmaceuticals (NASDAQ: ARNA) moved up 1.79% to $8.51 in the pre-market session. Arena Pharmaceuticals shares have surged 464.87% over the past 52 weeks, while the S&P 500 index has gained 20.85% in the same period.

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.